0001232524-17-000115.txt : 20170515 0001232524-17-000115.hdr.sgml : 20170515 20170515172652 ACCESSION NUMBER: 0001232524-17-000115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170511 FILED AS OF DATE: 20170515 DATE AS OF CHANGE: 20170515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc CENTRAL INDEX KEY: 0001232524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981032470 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE STREET 2: WATERLOO ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 353-1-634-7800 MAIL ADDRESS: STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE STREET 2: WATERLOO ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILLER MICHAEL PATRICK CENTRAL INDEX KEY: 0001236514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33500 FILM NUMBER: 17846024 BUSINESS ADDRESS: STREET 1: C/O JAZZ PHARMACEUTICALS PLC STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD CITY: DUBLIN 4 STATE: L2 ZIP: 0 BUSINESS PHONE: 6504963552 MAIL ADDRESS: STREET 1: C/O JAZZ PHARMACEUTICALS PLC STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD CITY: DUBLIN 4 STATE: L2 ZIP: 0 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-05-11 0 0001232524 Jazz Pharmaceuticals plc JAZZ 0001236514 MILLER MICHAEL PATRICK 5TH FL, WATERLOO EXCHANGE WATERLOO RD DUBLIN 4 L2 IRELAND 0 1 0 0 EVP, US Commercial Ordinary Shares 2017-05-11 4 A 0 1000 0.0 A 22623 D Ordinary Shares 2017-05-15 4 S 0 200 152.98 D 22423 D Non-Qualified Stock Option (right to buy) 155.18 2017-05-11 4 A 0 2500 0.0 A 2027-05-10 Ordinary Shares 2500 2500 D These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of June 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, May 11, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. By: /s/Peter A Christou, as attorney in fact For: Michael Patrick Miller 2017-05-15